Drug Hypersensitivity Reactions: Pathomechanism and Clinical Symptoms

Naisbitt, 2000, Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment, Drug Saf, 23, 483, 10.2165/00002018-200023060-00002

Lazarou, 1998, Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies, JAMA, 279, 1200, 10.1001/jama.279.15.1200

Roujeau, 1994, Severe adverse cutaneous reactions to drugs, N Engl J Med, 331, 1272, 10.1056/NEJM199411103311906

Bigby, 1986, Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982, JAMA, 256, 3358, 10.1001/jama.256.24.3358

Hunziker, 1997, Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey, Allergy, 52, 388, 10.1111/j.1398-9995.1997.tb01017.x

Manfredi, 2004, Detection of specific IgE to quinolones, J Allergy Clin Immunol, 113, 155, 10.1016/j.jaci.2003.09.035

Pichler, 2007, Drug hypersensitivity: classification and relationship to T cell activation, 168

Griem, 1998, Allergic and autoimmune reactions to xenobiotics: how do they arise?, Immunol Today, 19, 133, 10.1016/S0167-5699(97)01219-X

Sanderson, 2007, Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling, J Immunol, 178, 5533, 10.4049/jimmunol.178.9.5533

Schnyder, 1997, Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones, J Clin Invest, 100, 136, 10.1172/JCI119505

Zanni, 1998, HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes, J Clin Invest, 102, 1591, 10.1172/JCI3544

Pichler, 2002, Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept, Curr Opin Allergy Clin Immunol, 2, 301, 10.1097/00130832-200208000-00003

Pichler, 2005, Direct T-cell stimulations by drugs–bypassing the innate immune system, Toxicology, 209, 95, 10.1016/j.tox.2004.12.014

Sieben, 2002, Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones, J Allergy Clin Immunol, 109, 1005, 10.1067/mai.2002.123872

Naisbitt, 2003, Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones, Mol Pharmacol, 63, 732, 10.1124/mol.63.3.732

Wu, 2007, Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity, J Allergy Clin Immunol, 119, 973, 10.1016/j.jaci.2006.12.617

Keller, 2010, Processing-dependent and -independent pathways for recognition of iodinated contrast media by specific human T cells, Clin Exp Allergy, 40, 257, 10.1111/j.1365-2222.2009.03425.x

Burkhart, 2002, Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides, Clin Exp Allergy, 32, 1635, 10.1046/j.1365-2222.2002.01513.x

von Greyerz, 2001, Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones, Int Immunol, 13, 877, 10.1093/intimm/13.7.877

Tassaneeyakul, 2009, Strong association between HLA-B∗5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population, Pharmacogenet Genomics, 19, 704, 10.1097/FPC.0b013e328330a3b8

Man, 2007, Association between HLA-B∗1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese, Epilepsia, 48, 1015, 10.1111/j.1528-1167.2007.01022.x

Hetherington, 2002, Genetic variations in HLA-B region and hypersensitivity reactions to abacavir, Lancet, 359, 1121, 10.1016/S0140-6736(02)08158-8

Mallal, 2002, Association between presence of HLA-B∗5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir, Lancet, 359, 727, 10.1016/S0140-6736(02)07873-X

Chessman, 2008, Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity, Immunity, 28, 822, 10.1016/j.immuni.2008.04.020

Yang, 2009, Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome, PLoS Comput Biol, 5, e1000441, 10.1371/journal.pcbi.1000441

Yang, 2007, HLA-B∗1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome, J Allergy Clin Immunol, 120, 870, 10.1016/j.jaci.2007.06.017

Mennicke, 2009, Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation, Am J Transplant, 9, 2197, 10.1111/j.1600-6143.2009.02788.x

Coombs, 1968, Classification of allergic reactions responsible for clinical hypersensitivity and disease, 575

Riezzo, 2010, Ceftriaxone intradermal test-related fatal anaphylactic shock: a medico-legal nightmare, Allergy, 65, 130, 10.1111/j.1398-9995.2009.02088.x

Christensen, 2008, Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge, J Allergy Clin Immunol, 122, 298, 10.1016/j.jaci.2008.05.026

Pumphrey, 2004, Anaphylaxis: can we tell who is at risk of a fatal reaction?, Curr Opin Allergy Clin Immunol, 4, 285, 10.1097/01.all.0000136762.89313.0b

Mertes, 2009, Perioperative anaphylaxis, Immunol Allergy Clin North Am, 29, 429, 10.1016/j.iac.2009.04.004

Brockow, 2009, Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study, Allergy, 64, 234, 10.1111/j.1398-9995.2008.01832.x

Florvaag, 2009, The pholcodine story, Immunol Allergy Clin North Am, 29, 419, 10.1016/j.iac.2009.04.002

Baldo, 2009, On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective, Clin Exp Allergy, 39, 325, 10.1111/j.1365-2222.2008.03171.x

Castells, 2009, Rapid desensitization for hypersensitivity reactions to medications, Immunol Allergy Clin North Am, 29, 585, 10.1016/j.iac.2009.04.012

Sampson, 2006, Second symposium on the definition and management of anaphylaxis: summary report–Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium, J Allergy Clin Immunol, 117, 391, 10.1016/j.jaci.2005.12.1303

Pumphrey, 2004, Fatal anaphylaxis in the UK, 1992–2001, Novartis Found Symp, 257, 116, 10.1002/0470861193.ch10

Tramer, 2006, Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review, BMJ, 333, 675, 10.1136/bmj.38905.634132.AE

Aitman, 2006, Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans, Nature, 439, 851, 10.1038/nature04489

Stokol, 2004, C1q governs deposition of circulating immune complexes and leukocyte Fcgamma receptors mediate subsequent neutrophil recruitment, J Exp Med, 200, 835, 10.1084/jem.20040501

Pichler, 2006, Adverse side-effects to biological agents, Allergy, 61, 912, 10.1111/j.1398-9995.2006.01058.x

Nassif, 2002, Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis, J Invest Dermatol, 118, 728, 10.1046/j.1523-1747.2002.01622.x

Schnyder, 1998, T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction, Clin Exp Allergy, 28, 1412, 10.1046/j.1365-2222.1998.00419.x

Britschgi, 2001, T-cell involvement in drug-induced acute generalized exanthematous pustulosis, J Clin Invest, 107, 1433, 10.1172/JCI12118

Schaerli, 2004, Characterization of human T cells that regulate neutrophilic skin inflammation, J Immunol, 173, 2151, 10.4049/jimmunol.173.3.2151

Keller, 2005, T cell-regulated neutrophilic inflammation in autoinflammatory diseases, J Immunol, 175, 7678, 10.4049/jimmunol.175.11.7678

Beeler, 2006, Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions, J Allergy Clin Immunol, 117, 455, 10.1016/j.jaci.2005.10.030

Takahashi, 2009, Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome, J Immunol, 182, 8071, 10.4049/jimmunol.0804002

Sullivan, 1989, Studies of the multiple drug allergy syndrome, J Allergy Clin Immunol, 83, 270

Gex-Collet, 2005, Multiple drug hypersensitivity–proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests, J Investig Allergol Clin Immunol, 15, 293

Hari, 2001, T cell involvement in cutaneous drug eruptions, Clin Exp Allergy, 31, 1398, 10.1046/j.1365-2222.2001.01164.x